{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:09:38Z","timestamp":1789614578319,"version":"build-2803163510"},"reference-count":186,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Since December 2019, the coronavirus 2019 (COVID-19) pandemic has rapidly spread and overwhelmed healthcare systems worldwide, urging physicians to understand how to manage this novel infection. Early in the pandemic, more severe forms of COVID-19 have been observed in patients with cardiovascular comorbidities, who are often treated with renin-angiotensin aldosterone system (RAAS)-blockers, such as angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), but whether these are indeed independent risk factors is unknown. The cellular receptor for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the membrane-bound angiotensin converting enzyme 2 (ACE2), as for SARS-CoV(-1). Experimental data suggest that expression of ACE2 may be increased by RAAS-blockers, raising concerns that these drugs may facilitate viral cell entry. On the other hand, ACE2 is a key counter-regulator of the RAAS, by degrading angiotensin II into angiotensin (1-7), and may thereby mediate beneficial effects in COVID-19. These considerations have raised concerns about the management of these drugs, and early comments shed vivid controversy among physicians. This review will describe the homeostatic balance between ACE-angiotensin II and ACE2-angiotensin (1-7) and summarize the pathophysiological rationale underlying the debated role of the RAAS and its modulators in the context of the pandemic. In addition, we will review available evidence investigating the impact of RAAS blockers on the course and prognosis of COVID-19 and discuss why retrospective observational studies should be interpreted with caution. These considerations highlight the importance of solid evidence-based data in order to guide physicians in the management of RAAS-interfering drugs in the general population as well as in patients with more or less severe forms of SARS-CoV-2 infection.<\/jats:p>","DOI":"10.3389\/fphys.2021.624052","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T04:44:53Z","timestamp":1613969093000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic"],"prefix":"10.3389","volume":"12","author":[{"given":"Simon B.","family":"Gressens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Leftheriotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Dussaule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Flamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard I.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Vidal-Petiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1291\/hypres.29.865","article-title":"Olmesartan is an Angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.","volume":"29","author":"Agata","year":"2006","journal-title":"Hypertens. Res."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108293","article-title":"Risk factors for mortality among COVID-19 patients.","volume":"166","author":"Albitar","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1161\/HYPERTENSIONAHA.120.15312","article-title":"Renin-angiotensin-aldosterone system inhibitors and outcome in patients with SARS-CoV-2 pneumonia: a case series study.","volume":"76","author":"Andrea","year":"2020","journal-title":"Hypertension"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/ndt\/gfv025","article-title":"Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease.","volume":"30","author":"Anguiano","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1313","article-title":"Drugs and the renin-angiotensin system in covid-19.","volume":"369","author":"Aronson","year":"2020","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.2353\/ajpath.2010.090565","article-title":"Ventilator-induced inflammatory response in lipopolysaccharide-exposed rat lung is mediated by angiotensin-converting enzyme.","volume":"176","author":"Asperen","year":"2010","journal-title":"The Am. J. Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1101\/2020.02.07.939389","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.","volume":"583","author":"Bao","year":"2020","journal-title":"Microbiology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-020-00880-6","article-title":"Effect of renin-angiotensin-aldosterone system inhibitors in patients with COVID-19: a systematic review and meta-analysis of 28,872 patients.","volume":"22","author":"Baral","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin. Sci."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1282","article-title":"Coronavirus Disease 2019 (COVID-19) infection and renin angiotensin system blockers.","volume":"5","author":"Bavishi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ejhf.1924","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust.","volume":"22","author":"Bean","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.cmi.2020.07.024","article-title":"Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.","volume":"26","author":"Berenguer","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1198","article-title":"Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa.","author":"Boulle","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235248","article-title":"Predictors of severe or lethal COVID-19, including angiotensin converting enzyme inhibitors and Angiotensin II receptor blockers, in a sample of infected Italian citizens.","volume":"15","author":"Bravi","year":"2020","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin\u2013angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.","volume":"123","author":"Burchill","year":"2012","journal-title":"Clin. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1113\/expphysiol.2011.063156","article-title":"Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition: angiotensin-converting enzyme 2 and chronic kidney disease.","volume":"97","author":"Burrell","year":"2012","journal-title":"Exp. Physiol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans.","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur. Heart J."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4260","article-title":"Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.","volume":"345","author":"Caldeira","year":"2012","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ehjcvp\/pvaa056","article-title":"Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality.","volume":"6","author":"Cannata","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cmi.2020.05.041","article-title":"Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019\u2014a multi-centre observational study.","volume":"26","author":"Cen","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B22","doi-asserted-by":"publisher","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.16724","article-title":"Concerns on the specificity of commercial ELISAs for the measurement of Angiotensin-(1-7) and Angiotensin II in human plasma.","author":"Chappell","year":"2021","journal-title":"Hypertension"},{"key":"B24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.34067\/KID.0003792020","article-title":"Outcomes associated with the use of renin-angiotensin-aldosterone system blockade in hospitalized patients with SARS-CoV-2 infection.","volume":"360","author":"Chaudhri","year":"2020","journal-title":"Kidney"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa920","article-title":"Distinct clinical characteristics and risk factors for mortality in female inpatients with Coronavirus Disease 2019 (COVID-19): a sex-stratified, large-scale cohort study in Wuhan, China.","author":"Chen","year":"2020","journal-title":"Clinical Infectious Diseases"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/s41375-020-0911-0","article-title":"Risk factors for death in 1859 subjects with COVID-19.","volume":"34","author":"Chen","year":"2020","journal-title":"Leukemia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV.","volume":"525","author":"Chen","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/HYPERTENSIONAHA.120.15829","article-title":"Clinical and proteomic correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in human heart failure.","volume":"76","author":"Chirinos","year":"2020","journal-title":"Hypertension"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa069","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection.","volume":"27","author":"Chodick","year":"2020","journal-title":"J. Travel Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002706","article-title":"Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor\/angiotensin II receptor blocker use during coronavirus disease 2019: beyond confounding.","author":"Cohen","year":"","journal-title":"J. Hypertens."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1161\/CIRCRESAHA.120.317205","article-title":"Response by cohen et al to letter regarding article, \u201cassociation of inpatient use of angiotensin-converting enzyme inhibitors and Angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19\u201d.","volume":"126","author":"Cohen","year":"","journal-title":"Circ. Res."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin\u2013angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.","author":"Cohen","year":"2021","journal-title":"Lancet Respir. Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.5313","article-title":"Clinical outcomes in young us adults hospitalized with COVID-19.","author":"Cunningham","year":"2020","journal-title":"JAMA Internal Medicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.","volume":"395","author":"de Abajo","year":"2020","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an Angiotensin II Type I receptor\u2013dependent mechanism.","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa041","article-title":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.","volume":"27","author":"Diaz","year":"2020","journal-title":"J. Travel Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts Angiotensin I to Angiotensin 1-9.","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02224-2","article-title":"COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness.","author":"Du","year":"2020","journal-title":"J. Thromb. Thrombol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","article-title":"Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.","volume":"15","author":"Epelman","year":"2009","journal-title":"J. Cardiac. Fail."},{"key":"B40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","article-title":"Detection of soluble angiotensin-converting enzyme 2 in heart failure.","volume":"52","author":"Epelman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","article-title":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","volume":"38","author":"Esler","year":"2020","journal-title":"J. Hypertens."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Medicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/qjmed\/hcz206","article-title":"Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-\u03baB and Nrf2 pathways.","volume":"112","author":"Fang","year":"2019","journal-title":"QJM Int. J. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/ajh\/hpaa096","article-title":"Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.","volume":"33","author":"Felice","year":"2020","journal-title":"Am. J. Hypertens."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","volume":"111","author":"Ferrario","year":"","journal-title":"Circulation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/j.1523-1755.2005.00675.x","article-title":"Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.","volume":"68","author":"Ferrario","year":"","journal-title":"Kid. Int."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1136\/heartjnl-2020-317336","article-title":"Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: a meta-analysis.","volume":"106","author":"Flacco","year":"2020","journal-title":"Heart"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015.","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.11301","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality.","volume":"324","author":"Fosb\u00f8l","year":"2020","journal-title":"JAMA"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1268","article-title":"Patient characteristics and outcomes of 11,721 patients with COVID19 hospitalized across the United States.","author":"Fried","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"B52","doi-asserted-by":"publisher","first-page":"C420","DOI":"10.1152\/ajpcell.00409.2004","article-title":"Distinct roles for ANG II and ANG-(1\u20137) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.","volume":"290","author":"Gallagher","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"H2373","DOI":"10.1152\/ajpheart.00426.2008","article-title":"Regulation of ACE2 in cardiac myocytes and fibroblasts.","volume":"295","author":"Gallagher","year":"","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","article-title":"MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides.","volume":"295","author":"Gallagher","year":"","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.","volume":"41","author":"Gao","year":"2020","journal-title":"Eur. Heart J."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238281","article-title":"Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy.","volume":"15","author":"Giorgi Rossi","year":"2020","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/ehjcvp\/pvaa074","article-title":"Outcomes of renin\u2013angiotensin\u2013aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.","volume":"6","author":"Greco","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa064","article-title":"A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.","author":"Grover","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/srep19840","article-title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus.","volume":"6","author":"Gu","year":"2016","journal-title":"Sci. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of severe acute respiratory syndrome.","volume":"170","author":"Gu","year":"2007","journal-title":"Am. J. Pathol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYPERTENSIONAHA.120.15572","article-title":"Decreased mortality of COVID-19 with renin-angiotensin-aldosterone system inhibitors therapy in patients with hypertension: a meta-analysis.","volume":"76","author":"Guo","year":"2020","journal-title":"Hypertension"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US.","volume":"180","author":"Gupta","year":"2020","journal-title":"JAMA Intern. Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1113\/expphysiol.2007.041855","article-title":"Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats: renal ACE and ACE2 during ACE inhibition and low salt.","volume":"93","author":"Hamming","year":"2008","journal-title":"Exp. Physiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.taap.2010.02.009","article-title":"Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2.","volume":"245","author":"Han","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/cid\/ciaa329","article-title":"Is there an association between COVID-19 mortality and the renin-angiotensin system? A call for epidemiologic investigations.","volume":"71","author":"Hanff","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","article-title":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme.","volume":"532","author":"Harmer","year":"2002","journal-title":"FEBS Lett."},{"key":"B69","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.arcmed.2020.07.003","article-title":"Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico.","volume":"51","author":"Hern\u00e1ndez-Galdamez","year":"2020","journal-title":"Arch. Med. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"271.e8","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002515","article-title":"Influence of inhibitors of the renin\u2013angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients.","author":"Holt","year":"2020","journal-title":"J. Hypertens."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4595","article-title":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients.","volume":"5","author":"Huang","year":"2014","journal-title":"Nat. Commun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/HYPERTENSIONAHA.120.15324","article-title":"Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian society of hypertension.","volume":"76","author":"Iaccarino","year":"2020","journal-title":"Hypertension"},{"key":"B74","doi-asserted-by":"publisher","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","article-title":"Angiotensin II AT 1 receptors regulate ACE2 and angiotensin-(1\u20137) expression in the aorta of spontaneously hypertensive rats.","volume":"289","author":"Igase","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure.","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.22310","article-title":"Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection.","volume":"3","author":"Ioannou","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B77","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of Angiotensin II receptors.","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.bbrc.2004.08.208","article-title":"ACE1 polymorphism and progression of SARS.","volume":"323","author":"Itoyama","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"H2166","DOI":"10.1152\/ajpheart.00061.2006","article-title":"Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.","volume":"291","author":"Jessup","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1101\/2020.05.19.20106781","article-title":"Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin converting enzyme 2 (ACE2) in the kidney.","volume":"41","author":"Jiang","year":"2020","journal-title":"Cardiovasc. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1093\/cid\/ciaa624","article-title":"Association of renin-angiotensin-aldosterone system inhibitors with Coronavirus Disease 2019 (COVID-19)- related outcomes in Korea: a nationwide population-based cohort study.","volume":"71","author":"Jung","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"H1351","DOI":"10.1152\/ajpheart.01186.2004","article-title":"Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure.","volume":"289","author":"Karram","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.RES.0000187500.24964.7A","article-title":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients.","volume":"97","author":"Keidar","year":"2005","journal-title":"Circ. Res."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1012","article-title":"Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the U.S. Coronavirus Disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET).","author":"Kim","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2353\/ajpath.2008.070762","article-title":"Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK\/p38 MAP kinase pathway.","volume":"172","author":"Koka","year":"2008","journal-title":"Am. J. Pathol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/cvr\/cvaa097","article-title":"Hypertension, the renin\u2013angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.","volume":"116","author":"Kreutz","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases.","volume":"6","author":"Kuba","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury.","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002658","article-title":"Association between renin\u2013angiotensin\u2013aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment.","author":"Lahens","year":"2020","journal-title":"J. Hypertens."},{"key":"B90","first-page":"121","article-title":"Severe acute respiratory syndrome: clinical and laboratory manifestations.","volume":"25","author":"Lam","year":"2004","journal-title":"Clin. Biochem. Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/jvim.15548","article-title":"Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease.","volume":"33","author":"Larouche-Lebel","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19145-6","article-title":"ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/path.1670","article-title":"Renal ACE2 expression in human kidney disease.","volume":"204","author":"Lely","year":"2004","journal-title":"J. Pathol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1113\/expphysiol.2007.040352","article-title":"Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor: endogenous inhibitor masks plasma ACE2 activity.","volume":"93","author":"Lew","year":"2008","journal-title":"Exp. Physiol."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.3.374","article-title":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.","volume":"290","author":"Lew","year":"2003","journal-title":"JAMA"},{"key":"B96","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/srep27911","article-title":"Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1\/2 and NF-\u03baB signaling pathways.","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"B98","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/SHK.0000000000000302","article-title":"Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation.","volume":"43","author":"Li","year":"2015","journal-title":"Shock"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa062","article-title":"Association between renin-angiotensin system inhibitors and COVID-19 complications.","author":"Liabeuf","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"B100","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000368486","article-title":"Urinary angiotensin converting enzyme 2 increases in patients with Type 2 Diabetic Mellitus.","volume":"40","author":"Liang","year":"2015","journal-title":"Kid. Blood Press Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/cid\/ciaa415","article-title":"Obesity in patients younger than 60 years is a risk factor for COVID-19 Hospital admission.","volume":"71","author":"Lighter","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/01.fjc.0000195306.61719.64","article-title":"Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.","volume":"47","author":"Liu","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ahj.2020.05.002","article-title":"Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\u2013The BRACE CORONA Trial.","volume":"226","author":"Lopes","year":"2020","journal-title":"Am. Heart J."},{"key":"B105","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.","volume":"19","author":"Lopes","year":"2021","journal-title":"JAMA."},{"key":"B106","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"195","DOI":"10.7326\/M20-1515","article-title":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: a living systematic review.","volume":"173","author":"Mackey","year":"2020","journal-title":"Ann. Internal Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of covid-19.","volume":"382","author":"Mancia","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s11255-016-1334-8","article-title":"Urinary angiotensin converting enzyme 2 is strongly related to urinary nephrin in type 2 diabetes patients.","volume":"48","author":"Mariana","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1164\/rccm.2108086","article-title":"Angiotensin converting enzyme insertion\/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome.","volume":"166","author":"Marshall","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.jacc.2020.07.069","article-title":"Coronavirus and cardiometabolic syndrome.","volume":"76","author":"Mechanick","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and Angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19).","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05983-z","article-title":"Risk factors for mortality in patients with COVID-19 in New York City.","author":"Mikami","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"905.e7","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2.","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"B116","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","article-title":"Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis.","volume":"396","author":"Narula","year":"2020","journal-title":"Lancet"},{"key":"B117","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061695","article-title":"Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study.","volume":"8","author":"Ortiz-P\u00e9rez","year":"2013","journal-title":"PLoS One"},{"key":"B119","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/HYPERTENSIONAHA.120.15289","article-title":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients.","volume":"76","author":"Pan","year":"2020","journal-title":"Hypertension"},{"key":"B120","doi-asserted-by":"publisher","first-page":"93.e2","DOI":"10.1016\/j.annepidem.2020.08.005","article-title":"Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico.","volume":"52","author":"Parra-Bracamonte","year":"2020","journal-title":"Ann. Epidemiol."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1091","article-title":"Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study.","author":"Perez-Guzman","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03062-7","article-title":"The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.","volume":"24","author":"Pons","year":"2020","journal-title":"Crit. Care"},{"key":"B124","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.dsx.2020.06.047","article-title":"The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.","volume":"14","author":"Pranata","year":"2020","journal-title":"Diabetes Metab. Syndrome Clin. Res. Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(20)32011-0","article-title":"Circulating ACE2: a novel biomarker of cardiovascular risk.","volume":"396","author":"Ramchand","year":"2020","journal-title":"Lancet"},{"key":"B126","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jcmg.2019.09.005","article-title":"Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis.","volume":"13","author":"Ramchand","year":"2020","journal-title":"JACC Cardiovasc. Imag."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198144","article-title":"Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.","volume":"13","author":"Ramchand","year":"2018","journal-title":"PLoS One"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/ki.2008.497","article-title":"Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease.","volume":"74","author":"Reich","year":"2008","journal-title":"Kid. Int."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/ije\/dyaa140","article-title":"Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort.","volume":"49","author":"Reilev","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of Covid-19.","volume":"382","author":"Reynolds","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/01.HYP.0000244543.91937.79","article-title":"Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study.","volume":"48","author":"Rice","year":"2006","journal-title":"Hypertension"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area.","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","article-title":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin\u2013angiotensin\u2013aldosterone inhibitors.","volume":"41","author":"Sama","year":"2020","journal-title":"Eur. Heart J."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2020.461","article-title":"Patient characteristics and admitting vital signs associated with coronavirus disease 2019 (COVID-19)-related mortality among patients admitted with noncritical illness.","author":"Sands","year":"2020","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1\u20137)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1\u20137).","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2060","article-title":"Association between renin\u2013angiotensin\u2013aldosterone system inhibitor use and COVID-19 Hospitalization and death: a 1,4 million patient Nation-Wide registry analysis.","author":"Savarese","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002584","article-title":"Baseline use of angiotensin-converting enzyme inhibitor\/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients.","author":"Shah","year":"2020","journal-title":"J. Hypertens."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/oby.22831","article-title":"High prevalence of obesity in severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation.","volume":"28","author":"Simonnet","year":"2020","journal-title":"Obesity"},{"key":"B139","doi-asserted-by":"publisher","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","article-title":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan.","volume":"296","author":"Soler","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.120.15464","article-title":"Association between renin-angiotensin-aldosterone system inhibitors and COVID-19 infection in South Korea.","volume":"76","author":"Son","year":"2020","journal-title":"Hypertension"},{"key":"B141","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","article-title":"Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications.","volume":"30","author":"Soro-Paavonen","year":"2012","journal-title":"J. Hypertens."},{"key":"B142","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41581-020-0279-4","article-title":"Controversies of renin\u2013angiotensin system inhibition during the COVID-19 pandemic.","volume":"16","author":"South","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1161\/HYPERTENSIONAHA.120.15948","article-title":"Severe acute respiratory syndrome Coronavirus 2, COVID-19, and the renin-angiotensin system: pressing needs and best research practices.","volume":"76","author":"Sparks","year":"2020","journal-title":"Hypertension"},{"key":"B144","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/cpt.1863","article-title":"Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence.","volume":"108","author":"Sriram","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/HYPERTENSIONAHA.120.16261","article-title":"Proteomic analysis reveals upregulation of ACE2 (Angiotensin-Converting Enzyme 2), the putative SARS-CoV-2 receptor in pressure\u2013but not volume-overloaded human hearts.","volume":"76","author":"Stegbauer","year":"2020","journal-title":"Hypertension"},{"key":"B146","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmacoepidemiology.","volume":"167","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.7150\/ijbs.7.1077","article-title":"Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting Enzyme-2\/Angiotensin 1-7\/ Mas receptor axis.","volume":"7","author":"Sukumaran","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3109\/10715762.2012.684878","article-title":"Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1\u20137 mas receptor.","volume":"46","author":"Sukumaran","year":"2012","journal-title":"Free Radic. Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.amjhyper.2007.05.008","article-title":"Effects of aldosterone and Angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in dahl salt-sensitive hypertensive rats.","volume":"20","author":"Takeda","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"B150","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/cid\/ciaa492","article-title":"Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for Coronavirus Disease 2019.","volume":"71","author":"Tedeschi","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B151","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A Human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase.","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s40264-020-00994-5","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of death in patients hospitalised with COVID-19: a retrospective italian cohort study of 43,000 patients.","volume":"43","author":"Trifir\u00f2","year":"2020","journal-title":"Drug Saf."},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1177\/1470320316668435","article-title":"Circulating ACE2 activity correlates with cardiovascular disease development.","volume":"17","author":"Uri","year":"2016","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19.","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/jmv.26337","article-title":"Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study.","volume":"93","author":"van Gerwen","year":"2020","journal-title":"J. Med. Virol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1042\/CS20090318","article-title":"Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition.","volume":"118","author":"Velkoska","year":"2010","journal-title":"Clin. Sci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","article-title":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors.","volume":"47","author":"Vuille-dit-Bille","year":"2015","journal-title":"Amino Acids"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/europace\/euw246","article-title":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling.","volume":"19","author":"Walters","year":"2016","journal-title":"Europace"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China.","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B160","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.120.047049","article-title":"Angiotensin converting enzyme 2: a double-edged sword.","volume":"142","author":"Wang","year":"2020","journal-title":"Circulation"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3892\/ijmm.2016.2737","article-title":"Enalapril protects against myocardial ischemia\/reperfusion injury in a swine model of cardiac arrest and resuscitation.","volume":"38","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"B162","first-page":"1246","article-title":"Crosstalk between ACE2 and PLGF regulates vascular permeability during acute lung injury.","volume":"8","author":"Wang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","article-title":"Status of hypertension in China: results from the China hypertension survey, 2012\u20132015.","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/jcb.21248","article-title":"Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung.","volume":"101","author":"Wiener","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"B165","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY.","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1165\/rcmb.2011-0289OC","article-title":"LPS-stimulated cytokine production in Type I cells is modulated by the renin\u2013angiotensin system.","volume":"46","author":"Wong","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist: ARDS leads to reduced ratio of ACE\/ACE2 activities.","volume":"225","author":"W\u00f6sten-van Asperen","year":"2011","journal-title":"J. Pathol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/2020.02.11.944462","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.","volume":"367","author":"Wrapp","year":"2020","journal-title":"Microbiology"},{"key":"B169","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/HYPERTENSIONAHA.120.15782","article-title":"Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.","volume":"76","author":"Wu","year":"2020","journal-title":"Hypertension"},{"key":"B170","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1002\/jmv.26168","article-title":"Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.","volume":"92","author":"Wu","year":"2020","journal-title":"J. Med. Virol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1681\/ASN.2020050667","article-title":"Kidney and lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: implications for COVID-19.","volume":"31","author":"Wysocki","year":"2020","journal-title":"JASN"},{"key":"B172","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice.","volume":"55","author":"Wysocki","year":"2006","journal-title":"Diabetes"},{"key":"B173","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11427-015-4814-7","article-title":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse.","volume":"58","author":"Yan","year":"2015","journal-title":"Sci. China Life Sci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of Angiotensin II receptor blockers and ACE (Angiotensin-Converting Enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study.","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury.","volume":"4","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"B176","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.acvd.2013.01.004","article-title":"Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats.","volume":"106","author":"Yang","year":"2013","journal-title":"Arch. Cardiovasc. Dis."},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway.","volume":"113","author":"Ye","year":"2020","journal-title":"Exp. Mol. Pathol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.amepre.2020.05.002","article-title":"Clinical characteristics, associated factors, and predicting COVID-19 mortality risk: a retrospective study in Wuhan, China.","volume":"59","author":"Yu","year":"2020","journal-title":"Am. J. Prev. Med."},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm.2020.03.126","article-title":"Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.","volume":"21","author":"Zhang","year":"2020","journal-title":"Rev. Cardiovasc. Med."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and Angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19.","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104927","article-title":"ACEI\/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis.","volume":"158","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"L1015","DOI":"10.1152\/ajplung.00163.2018","article-title":"ACE-2\/ANG1-7 ameliorates ER stress-induced apoptosis in seawater aspiration-induced acute lung injury.","volume":"315","author":"Zhang","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4077\/CJP.2014.BAD268","article-title":"Alteration of cardiac ACE2\/Mas expression and cardiac remodelling in rats with aortic constriction.","volume":"57","author":"Zhang","year":"2014","journal-title":"Chinese J. Physiol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1161\/HYPERTENSIONAHA.120.15622","article-title":"Comparative impacts of ACE (Angiotensin-Converting Enzyme) inhibitors versus Angiotensin II receptor blockers on the risk of COVID-19 mortality.","volume":"76","author":"Zhou","year":"","journal-title":"Hypertension"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","volume":"395","author":"Zhou","year":"","journal-title":"Lancet"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.","volume":"5","author":"Zou","year":"2014","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.624052\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T04:44:59Z","timestamp":1613969099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.624052\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":186,"alternative-id":["10.3389\/fphys.2021.624052"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.624052","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"article-number":"624052"}}